A 91ÁÔÆæ biology student played a pivotal role in a groundbreaking discovery by researchers at MD Anderson Cancer Center: the COVID vaccine can enhance the effectiveness of immunotherapy treatments, offering new hope to cancer patients worldwide.
A new study reveals bridges in North America and Africa are most at risk of failure. 91ÁÔÆæ researcher Pietro Milillo and an international team are turning to satellites for the solution.
With funding from the NIH, UH leads a translational effort turning enzyme-targeting science into urgently needed treatments for Cryptosporidium infections — which are caused by a life-threatening pathogen and have no existing cure.
Leveraging the 91ÁÔÆæ’s strengths in biomedical research and education, the Texas Medical Center is partnering with UH to launch an incubator for kidney, urologic and hematologic training, creating a pipeline of health care workforce success.
The 91ÁÔÆæ is a national leader in vision science, receiving more National Eye Institute research funding than any other institution in Texas and placing among the top 10 recipients nationwide.
91ÁÔÆæ College of Optometry Professor John O’Brien, a leading expert on retinal neuroscience, has received $2.6 million from the National Eye Institute to continue more than 20 years of research on electrical synapses and gap junction plasticity, which affects not just the retina, but also a wide range of other neurological functions.